Background: Hypertension is a risk factor of diabetes. However, the underlying mechanisms are not fully elucidated. Therefore, we investigated this issue in a prospective cohort in Taiwan.

Methods: A total of 1177 subjects without diabetes at baseline were enrolled from 20to 2016 at National Taiwan University Hospital Yun-Lin branch with a median follow-up period of 4.5 years. Diabetes was diagnosed by the results of OGTT and HbA1c, or if antidiabetic agents were used. Insulin resistance index by the Homeostatic model assessment 2 (HOMA2-IR) were used to estimate insulin resistance.

Results: Subjects with hypertension by the JNC7 criteria had higher HOMA-IR at baseline and was associated with increased incidence of diabetes, adjusted for HOMA2-%B, HOMA2-IR, BMI, HbA1c, plasma triglyceride, age, gender, family history of diabetes and plasma CRP (adjusted HR 1.51, 95% CI 1.04-2.20, p=0.030). Subjects with treated hypertension had the highest risk of diabetes, followed by subjects with newly-diagnosed hypertension, compared with subjects with pre-hypertension and normal subjects. The progression rate of HOMA2-IR every 5 years (δHOMA2-IR/5 year) was higher in subjects with hypertension than in subjects without hypertension (adjusted p=0.001). Subjects with treated hypertension had the highest δHOMA2-IR/5 year, followed by subjects with newly-diagnosed hypertension, compared with normal subjects (adjusted p for trend=0.05). However, hypertension by the 2017 ACC/AHA criteria was not significantly associated with incident diabetes in adjusted models. The δHOMA2-IR/5 year for hypertension by this criteria was lower than that by the JNC7 criteria.

Conclusion: Hypertension is associated with an accelerated progression of insulin resistance and an increased risk of diabetes. Application of 2017 ACC/AHA criteria for hypertension attenuates the associations.

Disclosure

C. Lin: None. H. Li: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.